DBV Technologies S.A. (DBVT)
Nasdaq: DBVT · Biological Products, (No Diagnostic Substances) · Chatillon, FR · filing with the SEC since 2014
Who owns DBV Technologies S.A.
As filed with the SECHolders of 5% or more
7
Baker Bros. Advisors LP holds 9.99% of Ordinary shares, nominal value 0.10 euro per share, as its SCHEDULE 13D/A filed Jan 14, 2026 says.
Directors and officers
11
report now, of 24 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Baker Bros. Advisors LP
SCHEDULE 13D/A · filed Jan 14, 2026 · Ordinary shares, nominal value 0.10 euro per share · 17.1% in Mar 31, 2025
Suvretta Capital Management, LLC
SCHEDULE 13G · filed Apr 11, 2025 · Ordinary shares, nominal value 0.10 euro per share
Janus Henderson Group PLC
SCHEDULE 13G/A · filed Jan 8, 2026 · Common Stock · 2.6% in Dec 12, 2025
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed May 13, 2026 · Ordinary Shares, nominal value 0.10 euro per share · 9.99% in Aug 12, 2025
Raymond Debbane
SCHEDULE 13G/A · filed May 5, 2026 · Ordinary Shares, nominal value Euro 0.10 per share · 6.2% in Feb 13, 2026
MPM BioImpact LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Shares, nominal value 0.10 euro per share · 8.8% in May 15, 2026
RA Capital Management, L.P.
SCHEDULE 13G · filed Aug 6, 2026 · Ordinary shares, nominal value EUR 0.10 per share
Caisse des Depots
SCHEDULE 13D/A · filed Jan 7, 2026 · Ordinary Shares, nominal value EUR0.10 per share · reported falling below 5%, from 5.3% in Jan 5, 2026
Vivo Opportunity Fund Holdings, L.P.
SCHEDULE 13G/A · filed May 12, 2026 · Ordinary shares, nominal value 0.10 euro per share, represented by American Depository Shares · reported falling below 5%, from 5.7% in Feb 13, 2026
Artisan Partners Asset Management Inc.
SCHEDULE 13G/A · filed May 13, 2026 · American Depositary Shares · reported falling below 5%, from 7% in Feb 3, 2026
Kenneth Griffin
SCHEDULE 13G/A · filed Feb 17, 2026 · Ordinary shares, nominal value EUR0.10 per share (the "Shares") · reported falling below 5%, from 6.4% in Apr 14, 2025
Braidwell LP
SCHEDULE 13G/A · filed Feb 14, 2025 · Ordinary shares, nominal value 0.10 euro per share · reported falling below 5%
Venrock Healthcare Capital Partners II, L.P.
SCHEDULE 13G/A · filed Feb 17, 2026 · Ordinary Shares, nominal value 0.01 euro per share · reported falling below 5%, from 8.2% in Nov 14, 2025
What DBVT reports owning in othersstakes of 5% or more, and other ties
DBV Technologies S.A. reports no stake in another company in the record.
Insider tradesForm 4
4sales
0purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 29 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Epic Bpifrance | other | 3 | $15.5M | 0 | 0 | $0 |
| Mohideen Pharis | Chief Medical Officer | 4 | $0 | 0 | 0 | $0 |